A33. BIOMARKERS, ALLERGY AND IMMUNE RESPONSES IN COVID-19

COVID-19 and Biologics in Severe Asthmatic Patients: A Multicenter Retrospective Analysis

Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1278 S. Jiang, C. Pathak, S. Cao, W. Collins, L. Eggert, P. Akuthota, R. Chinthrajah

Soluble Cluster of Differentiation 36 (sCD36) as a Biomarker for Outcomes in Coronavirus Disease (COVID-19) Acute Respiratory Distress Syndrome (ARDS)

Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1284 F. Alghanim, T. Mohan, J. Hasday, C. Shanholtz, K. Birukov

Plasma Markers of Lung Injury and Remodeling Are Associated with Radiographic Features of Fibrosis in Patients with COVID-19 Acute Respiratory Distress Syndrome

Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1287 S. Holton, E. Morrell, S. Pipavath, P. Bhatraju, M. Wurfel, C. Mikacenic